Effects of 5-fluorouracil on Mouse Bone Marrow
Overview
Authors
Affiliations
5-Fluorouracil (150 mg/kg) was injected intravenously into 11-week-old male mice. Its effects on marrow structure over the following 9 d were assessed using light microscopic examination of semi-thin transverse sections of decalcified humeri. The extravascular compartment became markedly depleted of cells and decreased in size, reaching a minimum on day 5 post-treatment. Proliferating haematopoietic cells disappeared within 2 d. Post-replicative erythrocytic cells underwent extra-vascular phagocytosis by resident macrophages, whilst mature granulocytes continued to pass into the circulation. Repopulation was underway by day 6, and re-expansion of the extravascular compartment by day 7 when megakaryocytes, of larger than normal average size, occupied most of the extravascular compartment. Megakaryocyte dominance gave way over days 8 and 9 as other haematopoietic cells proliferated and the extravascular compartment continued to enlarge. The significance of the results is discussed in relation to marrow micro-circulation, egress of haematopoietic cells into the circulation, and cell proliferation in the marrow. Endotoxin, administered 4 h after 5-fluorouracil, accelerated depletion of the marrow and recovery of haematopoiesis by about 1 d.
Mechanical confinement prevents ectopic platelet release.
Guinard I, Brassard-Jollive N, Ruch L, Weber J, Eckly A, Boscher J Proc Natl Acad Sci U S A. 2024; 121(38):e2407829121.
PMID: 39236232 PMC: 11420179. DOI: 10.1073/pnas.2407829121.
Tang D, Qiu R, Qiu X, Sun M, Su M, Tao Z Gut Microbes. 2024; 16(1):2355693.
PMID: 38780487 PMC: 11123560. DOI: 10.1080/19490976.2024.2355693.
Li J, Williams M, Park H, Bastos H, Wang X, Prins D Blood. 2022; 140(14):1592-1606.
PMID: 35767701 PMC: 7614316. DOI: 10.1182/blood.2021014009.
Nesbitt N, Malone L, Liu Z, Jares A, Gnatenko D, Ma Y Free Radic Biol Med. 2020; 164:164-174.
PMID: 33359909 PMC: 8311568. DOI: 10.1016/j.freeradbiomed.2020.12.015.
Tanno T, Zhang P, Lazarski C, Liu Y, Zheng P Blood Adv. 2018; 1(15):1107-1119.
PMID: 29296753 PMC: 5728314. DOI: 10.1182/bloodadvances.2017004705.